Intraocular lenses (IOLs), implanted in the eye as treatment for cataracts or myopia, are a growing global market in an ageing population, one estimated to be worth more than $4.5 billion by 2022.
The report published on the global Intraocular Lens (IOL) is a comprehensive analysis of the various factors that either positively or negatively affect market growth. The report also introduces the ...
Copenhagen, Denmark: Patients who have a new type of lens implanted in their eyes during surgery for cataracts or to correct their eyesight have excellent or good vision over distances both near and ...
PanOptix delivers an exceptional combination of near, intermediate and distance vision and substantially reduces the need for glasses 1,2 More than ninety-nine percent of PanOptix patients in the FDA ...
Morgan Micheletti, MD, left, and Lilliana Werner, MD, PhD, display some of the IOLs from space at the Moran Eye Center. In a first-of-its-kind project, Micheletti partnered with a NASA and Space ...
PanOptix is already one of the leading presbyopia-correcting IOLs in more than 70 countries. It is designed for today’s active lifestyles, from viewing mobile devices and computer screens to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results